CPT-11+Pmab
€–Ϊ–Ό Šξ€—Κ ’PˆΚ }ަ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 @
‘S‘ΜƒXƒPƒWƒ…[ƒ‹ œ ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x @ @ @ @ @ @ @ @ @ @ @ @ @ @
ƒCƒŠƒmƒeƒJƒ“iCPT-11) 150 mL/‡u š @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @
ƒxƒNƒeƒBƒrƒbƒNƒX(P-mab) 6 mg/‡s š @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @
@ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @
@ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @
@ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @
y’ˆΣƒ`ƒ…ƒEƒCŽ–€ƒWƒRƒEz